GLP-1 Drugs Cut Death Risk 33% in Diabetics After Heart Attack
A new meta-analysis of 37,393 patients finds GLP-1 receptor agonists may reduce mortality and major cardiac events in type 2 diabetics with prior MI.
136 articles
A new meta-analysis of 37,393 patients finds GLP-1 receptor agonists may reduce mortality and major cardiac events in type 2 diabetics with prior MI.
A systematic review of RCTs finds night fasting windows improve glucose and lipid markers in shift workers, though evidence remains thin.
A new review reveals how senescent healthy cells within tumors quietly drive cancer progression and therapy resistance.
Biomolecular condensates formed by liquid-liquid phase separation offer a new platform for clearing disease-causing proteins conventional drugs can't target.
A new narrative review finds IF activates powerful antioxidant pathways, but warns that clinical proof in humans remains thin and short-term.
New review links physical activity to glymphatic function — the brain's built-in detox network that flushes neurotoxic proteins.
A Lancet systematic review finds interactive, personalized dementia prevention programs outperform mass media campaigns in changing real-world behavior.
A new Cell Metabolism review reveals how redox imbalance breaks immune tolerance, fueling lupus, rheumatoid arthritis, and MS.
A new minireview reveals early vascular aging, endothelial dysfunction, and insulin resistance may drive MS pathogenesis before disability sets in.
A new review maps how blood stem cell metabolism shifts with aging and how leukemia hijacks those changes — pointing to targeted therapeutic strategies.
A new review traces how aging science evolved from single-cause theories to partial reprogramming with Yamanaka factors as a lifespan-extending strategy.
A new Nature Metabolism review reveals how mitochondrial maintenance systems govern healthy aging — and how NAD+, AMPK, and caloric restriction may restore them.